TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Firm” or “Blueberries“), a Latin American licensed producer of medicinal hashish and cannabis-derived merchandise, at this time introduced its wholly owned subsidiary Blueberries SAS has exported a complete of 150 kg of premium CBD 5% Full Spectrum Oil to Futura Farms Peru, a number one licensed distributor serving the Peruvian market.
That is the Firm´s largest sale to any buyer worldwide because the starting of the operations in 2018. The CBD oil shipped might be used as the first ingredient for compounding formulations that Futura Farms is distributing to pharmaceutical institutions which have fulfilled their Good Storage Practices (“GSP”) necessities issued by Peru’s Normal Directorate of Medicines, Provides and Medicine (“DIGEMID”). Given the dimensions of the cargo, the Firm estimates that roughly 2.500 sufferers will profit from the resultant completed formulation.
“Over the previous six months we’ve centered most of our efforts on quickly bringing our cultivation and extraction operations to most effectivity, and we really feel that we are actually able to tackle the problem of increasing our business operations and connecting with world demand. This sale to our accomplice in Peru is critical due to its dimension and since it provides us confidence that we’re heading in the right direction”, stated Jose Maria Forero, President of the operations in Latin America.
Facundo Garreton, Chief Govt Officer and Chairman of the Board, added that, “Blueberries Medical Corp.’s has achieved its short-term objectives by lowering fastened construction prices and bills, and specializing in income era. In that sense, Firm expects generate greater than 7x revenues compared with earlier fiscal 12 months. Lastly, Mr. Garreton talked about he’s excited with the way forward for the corporate attributable to latest Non-public Placement that came about on early September. That capital injection of USD 1.5M will present the required assets to assist operation, whereas increasing funding in property plant and new tools, and getting the EUGMP certification to start out promoting our merchandise to abroad markets”.
About Blueberries Medical Corp.
Blueberries is a Latin American licensed producer of naturally grown premium high quality hashish with its main operations ideally situated within the Bogotá Savannah of central Colombia. The Firm is led by a specialised crew with proprietary experience in agriculture, genetics, extraction, drugs, pharmacology and advertising and marketing, Blueberries is totally licensed for the cultivation, manufacturing, home distribution, and worldwide export of CBD and THC-based medical hashish in Colombia. Blueberries’ mixture of main scientific experience, agricultural benefits and distribution preparations has positioned the Firm to turn into a number one worldwide provider of naturally grown, processed, and standardized medicinal-grade hashish oil extracts and associated merchandise.
Further details about the Firm is on the market at www.blueberriesmed.com. For extra data, please contact:
Jose Forero, President, Latin American Operations
Tel: +57 310 345 8808
Guillermo Rodriguez, Chief Monetary Officer
Tel: +54 9 11 6015 2227
Cautionary Word Concerning Ahead-Trying Data
This information launch incorporates “forward-looking data” and “forward-looking statements” (collectively, “ahead wanting statements”) inside the that means of the relevant Canadian securities laws. All statements, apart from statements historic truth, are forward-looking statements and are primarily based on expectations, estimates and projections as on the date of this information launch. Any assertion that includes discussions with respect to predictions, expectations, beliefs, plans, projections, aims, assumptions, future occasions or efficiency (typically however not at all times utilizing phrases corresponding to “expects”, or “doesn’t count on”, “is predicted”, “anticipates” or “doesn’t anticipate”, “plans”, “finances”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such phrases and phrases or stating that sure actions, occasions or outcomes “might” or “may”, “would”, “may” or “will” be taken to happen or be achieved) should not statements of historic truth and could also be forward-looking statements. On this information launch, ahead wanting statements relate, amongst different issues, to: graduation of business manufacturing of CBD-dominant oils and merchandise, profitable implementation of full GMP requirements at its extraction facility to permit for added export potential to worldwide markets, reaching extra milestones is contemplated, or in any respect, capability to increase distribution networks, capability to increase and improve the Firm’s cultivation services in Colombia, inner expectations, expectations concerning the power of the Firm to entry new Latin American and worldwide markets, the power to draw and retain new prospects, and future enlargement plans together with growth of the cultivation, manufacturing, industrialization and advertising and marketing of hashish for business and scientific functions.
These forward-looking statements are primarily based on cheap assumptions and estimates of administration of the Firm on the time such statements have been made. Precise future outcomes might differ materially as forward-looking statements contain identified and unknown dangers, uncertainties and different components which can trigger the precise outcomes, efficiency or achievements of the Firm to materially differ from any future outcomes, efficiency or achievements expressed or implied by such forward-looking statements. Such components, amongst different issues, embrace: fluctuations typically macroeconomic situations; fluctuations in securities markets; expectations concerning the dimensions of the Colombian and worldwide medical hashish market and altering shopper habits; the power of the Firm to efficiently obtain its enterprise aims; plans for enlargement; political and social uncertainties; incapacity to acquire enough insurance coverage to cowl dangers and hazards; and the presence of legal guidelines and laws that will impose restrictions on cultivation, manufacturing, distribution and sale of hashish and hashish associated merchandise in Colombia, Argentina and elsewhere; and worker relations. Though the forward-looking statements contained on this information launch are primarily based upon what administration of the Firm believes, or believed on the time, to be cheap assumptions, the Firm can not guarantee shareholders that precise outcomes might be in line with such forward-looking statements, as there could also be different components that trigger outcomes to not be as anticipated, estimated or meant. Readers mustn’t place undue reliance on the forward-looking statements and knowledge contained on this information launch. The Firm assumes no obligation to replace the forward-looking statements of beliefs, opinions, projections, or different components, ought to they alter, besides as required by legislation.
Further data concerning the Firm, and different dangers and uncertainties referring to the Firm’s enterprise are contained underneath the heading “Danger Components” within the Firm’s Itemizing Assertion dated January 31, 2019, and such different danger components included within the administration’s dialogue and evaluation of the Company for the 12 months ended December 31, 2020, every filed on its issuer profile on SEDAR at www.sedar.com.
No inventory change, securities fee or different regulatory authority has authorized or disapproved the data contained herein.
